We could not find any results for your search.
Try a different term, or tell us what you need and we will point you in the right direction:
«My vocation is to care for every patient with excellence and compassion. Every procedure I carry out reflects my deep commitment to health and wellbeing, in the knowledge that behind every procedure there is a life and a renewed sense of hope.»Book an appointment
Dr Felipe Hernández Hernández is a specialist in Interventional Cardiology, with a career spanning the Spanish hospital sector and a particular focus on the treatment of complex coronary artery disease and structural heart disease, including advanced percutaneous interventional techniques.
He has consistently combined his clinical work with extensive research and teaching activities, participating in multicentre studies, serving on the editorial boards of scientific journals and contributing to clinical innovation projects in interventional cardiology. His professional practice is characterised by a rigorous, evidence-based approach, focused on providing personalised and technically advanced patient care.
Key milestones in his training include his university studies, his specialisation in cardiology, and his advanced training in management and interventional cardiology.
His key roles and responsibilities include his clinical practice and leadership in interventional cardiology units.
His most significant scientific publications include clinical studies and multicentre trials in interventional cardiology.
2025 |
Salinas P, Romaguera R, Gómez-Lara J, et al., Hernández Hernández F.
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease.
Heart Jnl. 2025.
doi:10.1136/heartjnl-2025-325773
2022 |
Romaguera R, Salinas P, Hernández-Hernández F, et al.
Amphilimus- versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
European Heart Journal. 2022;43(13):1320–1330.
doi:10.1093/eurheartj/ehab790
2022 |
Wiebe J, Hofmann FJ, Hernández FH, et al.
Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice: results from the European Absorb Consortium.
Catheterisation and Cardiovascular Interventions. 2022;99(3):533–540.
doi:10.1002/ccd.29932
2021 |
Lozano I, Rumoroso JR, Pérez de Prado A, et al., Hernández F.
Antiplatelet therapy after stenting at a crossroads: the simplest or personalised therapy?
JACC: Cardiovascular Interventions. 2021;14(8):929–930.
doi:10.1016/j.jcin.2021.03.019
2011 |
de la Torre Hernández JM, Hernández Hernández F, Alfonso F, et al.
Prospective application of pre-defined intravascular ultrasound criteria for the assessment of intermediate left main coronary artery lesions: results from the multicentre LITRO study.
Journal of the American College of Cardiology. 2011;58(4):351–358.
doi:10.1016/j.jacc.2011.02.064
Among the clinical areas on which he focuses most in his practice are the following cardiovascular conditions.
The techniques and procedures he routinely performs in his clinical practice include the following.
He is a member of leading scientific societies in the field of interventional cardiology.
Specialist assessment with personalised planning and support throughout the entire process.
Choose whichever of these three options is easiest for you.
Leave us your details and we will call you back as soon as possible.
The form below is in Spanish. If you would rather be assisted in English, please call us or request a call back.
Fill in the form below to arrange your medical appointment.
The form below is in Spanish. If you would rather be assisted in English, please call us or request a call back.